BenevolentAI
BenevolentAI's Overview
BenevolentAI is a clinical-stage AI drug discovery company that combines advanced AI and machine learning with cutting-edge science to decipher complex disease biology, generate novel insights, and accelerate the creation of more effective medicines. Their Benevolent Platform™ is used to understand disease mechanisms, identify novel drug targets, and develop potential drug candidates for a wide range of diseases. The company aims to reduce the traditionally high failure rates in drug development and bring new treatments to patients faster.
Where is BenevolentAI's Headquarters?
HQ Function
Global headquarters housing primary research and development labs, corporate functions, AI platform development, and strategic operations.
Notable Features:
State-of-the-art laboratories co-located with computational research teams, fostering a unique 'lab-in-the-loop' approach. Modern, open-plan office space designed for collaboration and innovation.
Work Culture:
A dynamic, intellectually stimulating, and mission-driven environment. Emphasizes interdisciplinary collaboration between scientists, AI researchers, and engineers. Focuses on scientific rigor, continuous learning, and a shared goal of impacting patient lives.
HQ Significance:
Serves as the central hub for BenevolentAI's pioneering research, technological innovation, and global strategy, driving its mission to revolutionize drug discovery.
Values Reflected in HQ: The headquarters' design and functionality reflect BenevolentAI's core values of innovation, collaboration, scientific excellence, and the pursuit of transformative solutions in healthcare.
Location:
BenevolentAI operates with a global outlook, primarily from its UK headquarters and US office, driving research and development applicable worldwide. The company collaborates with international pharmaceutical partners and research institutions to advance its drug discovery pipeline. Its AI platform analyzes global biomedical data, and its drug candidates are intended for global patient populations.
Street Address:
4-8 Maple Street
City:
London
State/Province:
Country:
United Kingdom
BenevolentAI's Global Presence
New York, NY, USA
Address: 120 West 45th Street, Suite 1001, New York, NY 10036, USA
To strengthen BenevolentAI's presence in the world's largest pharmaceutical market, facilitate partnerships, and tap into the rich ecosystem of talent and innovation in North America.
Cambridge, United Kingdom
Address: BioData Innovation Centre, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, United Kingdom
To engage with the vibrant Cambridge life sciences cluster, foster scientific collaborations, and access specialized talent and resources at the Wellcome Genome Campus.
Buying Intent Signals for BenevolentAI
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of BenevolentAI
As of April 2025, BenevolentAI' leadership includes:
Investors of BenevolentAI
BenevolentAI has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
BenevolentAI has seen key leadership changes over the past year, including a new CEO and CFO, aimed at steering the company through its next phase of growth and clinical development.
Departures
New Appointments:
Technology (Tech Stack) used by BenevolentAI
Discover the tools BenevolentAI uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
BenevolentAI Email Formats and Examples
BenevolentAI primarily uses the domain 'benevolent.ai' for its corporate email communications. Common formats observed for companies of this nature include combinations of first name, last name, and initials.
firstname.lastname@benevolent.ai or firstinitiallastname@benevolent.ai (e.g., j.doe@benevolent.ai or jdoe@benevolent.ai)
Format
example: jane.doe@benevolent.ai
Example
75%
Success rate
News and media
BenevolentAI PLC • March 7, 2024
BenevolentAI news title: BenevolentAI Announces Full Year Results for the Year Ended 31 December 2023
BenevolentAI reported its financial results for 2023, highlighting progress in its pipeline, strategic focus on key programmes, and ongoing development of its AI platform. The company outlined its operational achievements and financial position....more
BenevolentAI PLC • February 20, 2024
BenevolentAI news title: BenevolentAI announces positive topline Phase Ia results for BEN-8744, an oral PDE10 inhibitor for the treatment of Ulcerative Colitis
The company announced that BEN-8744, its lead asset for Ulcerative Colitis, met its primary safety and tolerability endpoints in a Phase Ia first-in-human trial. Pharmacokinetic and pharmacodynamic data were also encouraging....more
BenevolentAI PLC • July 6, 2023
BenevolentAI news title: BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer
BenevolentAI announced the appointment of Dr. Joerg Moeller as its permanent Chief Executive Officer, following his tenure as Interim CEO since April 2023. Dr. Moeller brings extensive experience in pharmaceutical R&D....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including BenevolentAI, are just a search away.